MedKoo Biosciences/Ostarine (MK2866)/202103/50g

Synonym:MK2866;MK2866;MK-2866;GTX024;GTX024;GTX-024;Ostarine;Enobosarm.

IUPAC/ChemicalName:((2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide)

InChiKey:JNGVJMBLXIUVRD-SFHVURJKSA-N

InChiCode:InChI=1S/C19H14F3N3O3/c1-18(27,11-28-15-6-2-12(9-23)3-7-15)17(26)25-14-5-4-13(10-24)16(8-14)19(20,21)22/h2-8,27H,11H2,1H3,(H,25,26)/t18-/m0/s1

SMILESCode:O=C(NC1=CC=C(C#N)C(C(F)(F)F)=C1)[C@@](C)(O)COC2=CC=C(C#N)C=C2

TechnicalData

AdditionalInformation

Ostarine(alsoknownasGTx-024andMK-2866)isaninvestigationalselectiveandrogenreceptormodulator(SARM)fromGTX,Incfortreatmentofconditionssuchasmusclewastingandosteoporosis,formerlyunderdevelopmentbyMerck&Company. GTxandMerckhadclinicaldevelopmentplanstoevaluateOstarineforthetreatmentofmusclelossinpatientswithCOPDandforthetreatmentofchronicsarcopenia.TheyhadagoalofinitiatinganOstarinePhaseIICOPDclinicaltrialinthefirstquarterof2010andanOstarinePhaseIIbchronicsarcopeniaclinicaltrialin2010.(source:http://en.wikipedia.org/wiki/Ostarine).
 
 

References

1:GirgisCM,MokbelN,DigirolamoDJ.Therapiesformusculoskeletaldisease:canwetreattwobirdswithonestone?CurrOsteoporosRep.2014Jun;12(2):142-53.doi:10.1007/s11914-014-0204-5.Review.PubMedPMID:24633910;PubMedCentralPMCID:PMC4083371.

2:SrinathR,DobsA.Enobosarm(GTx-024,S-22):apotentialtreatmentforcachexia.FutureOncol.2014Feb;10(2):187-94.doi:10.2217/fon.13.273.PubMedPMID:24490605.

3:DaltonJT,TaylorRP,MohlerML,SteinerMS.Selectiveandrogenreceptormodulatorsforthepreventionandtreatmentofmusclewastingassociatedwithcancer.CurrOpinSupportPalliatCare.2013Dec;7(4):345-51.doi:10.1097/SPC.0000000000000015.Review.PubMedPMID:24189892.

4:KimJ,WangR,VeverkaKA,DaltonJT.Absorption,distribution,metabolismandexcretionofthenovelSARMGTx-024[(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide]inrats.Xenobiotica.2013Nov;43(11):993-1009.doi:10.3109/00498254.2013.788233.Epub2013Apr22.PubMedPMID:24074268.

5:deRijkeE,EssersML,RijkJC,ThevisM,BoveeTF,vanGinkelLA,SterkSS.Selectiveandrogenreceptormodulators:invitroandinvivometabolismandanalysis.FoodAdditContamPartAChemAnalControlExpoRiskAssess.2013;30(9):1517-26.doi:10.1080/19440049.2013.810346.Epub2013Jul24.PubMedPMID:23883284.

6:MohdFauziF,KoutsoukasA,CunninghamA,GallegosA,SedefovR,BenderA.Computer-aided(insilico)approachesinthemode-of-actionanalysisandsafetyassessmentofostarineand4-methylamphetamine.HumPsychopharmacol.2013Jul;28(4):365-78.doi:10.1002/hup.2322.PubMedPMID:23881885.

7:FearonKH.Selectiveandrogenreceptormodulatorsincancercachexia?LancetOncol.2013Apr;14(4):271-2.doi:10.1016/S1470-2045(13)70068-8.Epub2013Mar14.PubMedPMID:23499391.

8:DobsAS,BocciaRV,CrootCC,GabrailNY,DaltonJT,HancockML,JohnstonMA,SteinerMS.Effectsofenobosarmonmusclewastingandphysicalfunctioninpatientswithcancer:adouble-blind,randomisedcontrolledphase2trial.LancetOncol.2013Apr;14(4):335-45.doi:10.1016/S1470-2045(13)70055-X.Epub2013Mar14.PubMedPMID:23499390.

9:GerberDE.Miscellaneousagents--cytotoxicsandhormonalagents.JThoracOncol.2012Dec;7(16Suppl5):S387-9.doi:10.1097/JTO.0b013e31826df198.Review.PubMedPMID:23160328.

10:DaltonJT,BarnetteKG,BohlCE,HancockML,RodriguezD,DodsonST,MortonRA,SteinerMS.TheselectiveandrogenreceptormodulatorGTx-024(enobosarm)improvesleanbodymassandphysicalfunctioninhealthyelderlymenandpostmenopausalwomen:resultsofadouble-blind,placebo-controlledphaseIItrial.JCachexiaSarcopeniaMuscle.2011Sep;2(3):153-161.Epub2011Aug2.PubMedPMID:22031847;PubMedCentralPMCID:PMC3177038.